Institutional Ownership
Ascendis Pharma A/S
CUSIP 04351PAD3NOTE 2.250% 4/0ASNDQ1 2026
Earnings
Quarterly EPS and revenue are sourced from SEC XBRL financial statements. We ingest the top issuers first; this fills in as coverage expands (or this security isn't mapped to an SEC filer yet).